Endogenous and chemical chaperones decrease ER stress markers in hIAPP-INS1E cells. by Lisa Cadavez (596155)

DGAT-1 Inhibitor A922500 decreases the pro-inflammatory profile and cell death induced by SARS-CoV-2 infection and reduces the viral load in human monocyte. by Suelen Silva Gomes Dias (9928813)

S5 Data - by Christoph Anders (4068499)

3D visualization of longitudinal T2w imaging. by Joshua Park (719780)

Decrease of mitochondrial protein levels in human OPMD muscle biopsies. by Aymeric Chartier (713911)

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

Fig 5 - by Timothy P. Szczykutowicz (11614088)

Subjects:

Mean decrease in accuracy (MDA) of top 15 urine metabolites. by Liam E. Broughton-Neiswanger (8447220)

“…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…”

Decrease of GFP-TbAtg8 fluorescence during starvation. by Remo S. Schmidt (546946)

<i>Trappc9</i> deficient mice show a decrease in brain weight and size. by Zhengzheng S. Liang (9333660)

“…X-Y plot shows the percentage of changes relative to the controls (100%) against the <i>p</i>-values (in log2 scale) testing the difference in 16-week aged <i>Trappc9-/-</i> mice comparing to their wild-type littermates at Lateral 0.72mm section (n = 4 brains in each group, 3 females and 1 male). …”

The effects of NAC on the decreased number of myotube formations caused by arecoline. by Yi-Xuan Li (6633845)

Model performance according to number of variables by 5-fold cross-validation. by Gazi Md. Salahuddin Mamun (13905678)

Chemically inhibiting LDHA or PDK1 decreases cell viability in Aβ resistant cells. by Jordan T. Newington (223389)

“…Similarly, 48 hr Aβ exposure significantly decreased cell viability in both PC12 (<b>C</b>) and B12 (<b>D</b>) resistant lines when cells were co-treated with 2.5 mM dichloroacetate (DCA), a chemical inhibitor of PDK1 (*P<0.01). …”

Pneumococci decrease epithelial surface fluid flow and particle transport. by Manfred Fliegauf (391677)

HDACi exposure in DHA-treated cells enhanced decreases of Mcl-1 and p-ERK. A. by Chris Zhiyi Zhang (111721)

Decrease in optical density of <i>gerP</i> mutants in L-alanine and inosine. by Katherine A. Carr (259428)

“…a<p>Spores were incubated in 0.5 mM L-alanine and 1 mM inosine. ∼65% decrease in OD₆₀₀ represents ∼100% germination. …”

Dominant negative Hif-2α decreases bacterial burden via an iNOS dependent mechanism. by Philip M. Elks (324793)